Skip to main content

Table 1 Baseline characteristics of the study population

From: Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome

Variables

Non-PCOS

PCOS

P value

Number

10772

1813

 

Age (years)

31.00 (28.00–34.00)

29.00 (27.00–31.00)

< 0.001

BMI (kg/m2)

21.08 (19.53–23.03)

22.51 (20.31–25.22)

< 0.001

SBP (mm Hg)

113.00 (105.00–121.00)

117.00 (108.00–125.00)

< 0.001

DBP (mm Hg)

71.00 (67.00–78.00)

74.00 (70.00–80.00)

< 0.001

FSH (IU/L)

7.70 (6.53–9.16)

6.64 (5.61–7.72)

< 0.001

LH (IU/L)

4.37 (3.29–5.79)

6.51 (4.64–8.80)

< 0.001

LH/FSH

0.55 (0.41–0.75)

0.98 (0.70–1.35)

< 0.001

E2 (pmol/L)

144.00 (101.00–190.25)

141.00 (98.00–195.00)

0.12

T (nmol/L)

1.21 (0.89–1.55)

1.65 (1.27–2.07)

< 0.001

FPG (mmol/L)

5.30 (5.00–5.60)

5.30 (5.00–5.60)

0.07

TG (mmol/L)

0.88 (0.65–1.24)

1.17 (0.81–1.78)

< 0.001

TC (mmol/L)

4.38 (3.90–4.90)

4.57 (4.07–5.16)

< 0.001

LDL (mmol/L)

2.39 (2.02–2.83)

2.58 (2.16–3.07)

< 0.001

HDL (mmol/L)

1.44 (1.25–1.66)

1.34 (1.15–1.59)

< 0.001

eGFR (mL/min/1.73m2)

125.97 (120.18–129.68)

126.79 (122.43–131.33)

< 0.001

Uric acid (mg/dL)

4.52 (3.95–5.16)

5.16 (4.40–6.02)

< 0.001

Hyperuricemia (%)

8.74%

25.48%

< 0.001

  1. The data are presented as the medians (interquartile ranges) for skewed variables or as proportions for categorical variables